Clinical trials
Paget Disease, Extramammary clinical trials
Below are recruiting paget disease, extramammary clinical trials, each written for real people, not researchers. We’re tracking 9 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT03564483Recruiting
Study for vulvar or anal skin cancer called EMPD
This study is for women with a specific rare skin cancer called extramammary Paget’s disease (EMPD) in the vulvar or perianal area. The goal is to better understand the condition and test an approach for people with primary or returning (recurrent) disease in those locations.
Rochester, MinnesotaAges 18 years+ - NCT03713203Recruiting
Light-based treatment for vulvar Paget’s disease
This study tests a special light treatment (photodynamic therapy) for non-invasive Paget’s disease on the vulva that has come back after surgery. It may help by treating remaining abnormal skin cells where surgery may not remove everything.
LilleAges 18 years+ - NCT06561555RecruitingPhase 2
Testing a new drug for advanced HER2-positive Paget's disease
This trial tests an investigational drug called Disitamab Vedotin for people with advanced Paget's disease that tests positive for HER2. It aims to see if the drug can shrink tumors or improve skin lesions.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT06791070RecruitingPhase 2
RC48-ADC plus immunotherapy for advanced scrotal Paget disease
This trial tests a combination of two drugs (RC48-ADC and JS001) for advanced scrotal Paget disease that has spread or cannot be removed by surgery. The goal is to see if this treatment can help shrink or control the cancer.
Fuzhou, FujianAges 18–80 - NCT06873815RecruitingPhase 2
Using a dye to help see cancer during vulvectomy for Paget's disease
This trial tests whether a fluorescent dye called fluorescein sodium can help surgeons see the edges of extramammary Paget's disease more clearly during vulvectomy, so they can remove all the cancer while sparing as much healthy tissue as possible.
Basking Ridge, New JerseyAges 18 years+ - NCT07117851RecruitingPhase 2
Study of disitamab vedotin and bicalutamide for HER2/AR-positive Paget's disease
This trial tests a combination of two drugs: disitamab vedotin (which attacks cancer cells with a certain protein) and bicalutamide (which blocks male hormones that can fuel cancer growth). It is for people with Paget's disease that has spread or cannot be removed, and whose cancer cells have specific protein markers called HER2 and AR.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT05859074RecruitingPhase 1
Testing MQ710 injections alone or with pembrolizumab for advanced cancers
This early-phase study tests MQ710, a medicine given by injection into a reachable tumor, to see how well it can control advanced cancers. Some participants also receive pembrolizumab, an immunotherapy, to help the immune system fight the cancer.
Basking Ridge, New JerseyAges 18 years+ - NCT06683846RecruitingPhase 2
Ivonescimab for advanced rare tumors: a safety & early-efficacy study
This trial tests a drug called ivonescimab in people with advanced, rare tumor types that have spread (stage IV). The goal is to see if the drug is safe and whether it can shrink tumors or slow their growth.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06684327RecruitingPhase 2
Study of three chemotherapy drugs for rare advanced cancers
This trial tests a combination of three chemotherapy drugs (albumin-paclitaxel, ifosfamide, and cisplatin) for people with certain rare cancers that have spread to other parts of the body (stage IV). It looks at how well the treatment works and if it is safe.
Shanghai, Shanghai MunicipalityAges 18 years+
Hear when a new Paget Disease, Extramammary trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for paget disease, extramammary?
- Yes. Clin2 currently lists 9 recruiting paget disease, extramammary studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a paget disease, extramammary trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a paget disease, extramammary trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.